Tag: pipeline

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross proceeds to Legend Biotech from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Legend Biotech, are expected to be approximately $226 million, excluding any proceeds from the exercise of the underwriters’ option to purchase additional ADSs. The offering is expected to close on June 23, 2026, subject to customary closing conditions.

Acquisition adds multiple immunology assets to Biogen’s portfolio, including a lead asset poised to enter Phase 1 development

Company Highlights Strategic Connectivity Across Key Domestic Producing Regions

SAN DIEGO, Calif., June 17, 2026 (GLOBE NEWSWIRE) -- International Land Alliance, Inc. (OTCQB: ILAL) ("ILA" or the "Company"), a leading developer of residential and resort communities in Baja California, Mexico, today announced the sale of seven properties at its flagship Rancho Costa Verde development. The transactions consisted of six residential lots and one completed home, generating total gross sales of $351,500.

Binding Master Supply Agreement secures a 750 MWh capacity commitment with a pathway to scale up to 2 GWh of Indensity™ deployments across Germany, Austria and Switzerland through 2031

~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~